Form: 8-K

Current report filing

June 13, 2016

8-K: Current report filing

Published on June 13, 2016

 
 




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549



FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 9, 2016

OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in charter)


Maryland
1-11316
38-3041398
(State of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)


200 International Circle
 Suite 3500
Hunt Valley, Maryland 21030
(Address of principal executive offices / Zip Code)

(410) 427-1700
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o       Written communications pursuant to Rule 425 under the Securities Act.
 
o       Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
 
o       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
 
o       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
 

 
 

 
Item 5.07                      Submission of Matters to a Vote of Security Holders.

On June 9, 2016, Omega Healthcare Investors, Inc. (“Omega”) held its Annual Meeting of Stockholders.

 At the Annual Meeting, there were present in person or by proxy 175,231,361 shares of Omega’s common stock, representing approximately 93% of the total outstanding eligible votes.  The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

Proposal  1: Election of Directors

   
Votes Cast in Favor
   
Votes Withheld
   
Broker Non-Votes
 
Norman R. Bobins
    136,369,835       952,672       37,908,854  
Craig R. Callen
    136,678,660       643,847       37,908,854  
Bernard J. Korman
    135,174,109       2,148,398       37,908,854  
Edward Lowenthal
    133,762,087       3,560,420       37,908,854  
Ben W. Perks
    135,248,414       2,074,093       37,908,854  
Stephen D. Plavin
    129,983,552       7,338,955       37,908,854  

Proposal 2: Ratification of the selection of Ernst & Young LLP as Omega’s independent auditor for 2014

For
Against
Abstentions
Broker Non-Votes
172,293,689
2,703,317
234,355
-

Proposal 3: Advisory vote on Omega’s executive compensation

For
Against
Abstentions
Broker Non-Votes
133,237,523
3,337,680
747,304
37,908,854


Each of the director nominees was elected, the selection of Ernst & Young LLP was ratified and the Company’s executive compensation was approved on an advisory basis.


 
 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OMEGA HEALTHCARE INVESTORS, INC.
(Registrant)

Dated:  June 13, 2016                                                                By: /s/ Robert O. Stephenson 
Robert O. Stephenson
Chief Financial Officer and Treasurer